The DDIC was founded in 2017 by the companies Bayer AG, LB Bohle GmbH, Merck KGaA (all Germany) and UCB S.A (Belgium), together with the university partners TU Dortmund and HHU Düsseldorf. INVITE GmbH is leading the consortium. The DDIC fosters international, multi-disciplinary networks in the area of research to advance in pharmaceutical science in close collaboration with academia and pharmaceutical industry along the value chain. For more information please refer to this link.
Parsum supports and participates in research coordinated by the DDIC with its innovative tools and software for process analysis technology (PAT), which are used in the pharmaceutical industry to support the development of new pharmaceutical processes.